Qing Qing Yi
Director/Board Member presso BEIGENE, LTD.
Patrimonio netto: 359 843 $ in data 31/03/2024
Profilo
Qing Qing Yi is currently serving as the Vice Chairman at Hisun Pfizer Pharmaceuticals Co., Ltd.
since 2017.
Additionally, Mr. Yi holds the position of Independent Non-Executive Director at BeiGene Ltd.
since 2014, Non-Executive Director at JD Health International, Inc. since 2020, and Partner at Hillhouse Capital Group Ltd.
since 2005.
Previously, Mr. Yi served as the Chairman at Genor Biopharma Holdings Ltd.
from 2018 to 2021 and as a Non-Executive Director at Shanghai Junshi Biosciences Co., Ltd.
from 2016 to 2021.
Mr. Yi also held director positions at Gossamer Bio, Inc. and Hibercell, Inc. Mr. Yi obtained an MBA from the University of Southern California in 2003 and completed undergraduate studies at Shanghai Maritime University in 1995.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BEIGENE LTD
0.00% | 15/06/2023 | 29 614 ( 0.00% ) | 359 843 $ | 31/03/2024 |
Posizioni attive di Qing Qing Yi
| Società | Posizione | Inizio |
|---|---|---|
| BEIGENE, LTD. | Director/Board Member | 01/10/2014 |
| JD HEALTH INTERNATIONAL INC. | Director/Board Member | 21/08/2020 |
Hillhouse Capital Group Ltd.
 Hillhouse Capital Group Ltd. Investment ManagersFinance Hillhouse Capital Group Ltd. operates as an investment management firm. It serves the consumer, TMT, industrials, and healthcare sectors and invests in companies across all equity stages. The company was founded by Zhang Lei in 2005 and is headquartered in Hong Kong. | Corporate Officer/Principal | 01/01/2005 |
Hisun Pfizer Pharmaceuticals Co., Ltd.
 Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Director/Board Member | 15/12/2017 |
Precedenti posizioni note di Qing Qing Yi
| Società | Posizione | Fine |
|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Chairman | 02/11/2021 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Director/Board Member | 29/06/2021 |
| GOSSAMER BIO, INC. | Director/Board Member | 19/12/2018 |
Hibercell, Inc.
 Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Director/Board Member | - |
Formazione di Qing Qing Yi
| University of Southern California | Masters Business Admin |
| Shanghai Maritime University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| BEIGENE, LTD. | Health Technology |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| JD HEALTH INTERNATIONAL INC. | Health Services |
| Aziende private | 3 |
|---|---|
Hillhouse Capital Group Ltd.
Hillhouse Capital Group Ltd. Investment ManagersFinance Hillhouse Capital Group Ltd. operates as an investment management firm. It serves the consumer, TMT, industrials, and healthcare sectors and invests in companies across all equity stages. The company was founded by Zhang Lei in 2005 and is headquartered in Hong Kong. | Finance |
Hisun Pfizer Pharmaceuticals Co., Ltd.
Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Health Technology |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Qing Qing Yi
